Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENTASA in active Crohn's Disease
2008-002100-26Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Crohn's disease comparing PENTASA 6 g/day with Placebo (2 arms). Primary endpoint: Clinical response at Week 10. Started Jul 2008; status: completed.
02
Drugs
Salcrozine
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2008-002100-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002100-26.